Benzinga | Nov 5, 2020 04:35PM EST

Eloxx Pharmaceuticals Q3 EPS $(0.16) Beats $(0.19) Estimate

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 50 percent increase over losses of $(0.32) per share from the same period last year.